This metabolite provides a PDE selectivity profile comparable to sildenafil and an in vitro potency for PDE5 close to fifty% of the guardian drug. Plasma concentrations of this metabolite are close to forty% of those viewed for sildenafil, so the metabolite accounts for about twenty% of sildenafil's pharmacologic effects.There have been postmarketi